Imagen de Portada

DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Yang, Cheng-Han, Thall, Peter F., Lin, Ruitao
Formato:	Preprint
Publicado:	2024
Materias:	Applications Methodology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mixture of Finite Mixtures Model for Basket Trial
por: Geng, Junxian, et al.
Publicado: (2020)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
por: Zhang, Fanni, et al.
Publicado: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
por: Li, Yuhan, et al.
Publicado: (2024)

Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
por: Zhang, Jiangshan, et al.
Publicado: (2024)

Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
por: Bao, Han, et al.
Publicado: (2025)

Mediation Analysis for Sparse and Irregularly Spaced Longitudinal Outcomes with Application to the MrOS Sleep Study
por: Ren, Rui, et al.
Publicado: (2025)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
por: Silva, Rebecca B., et al.
Publicado: (2025)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
por: Sokolova, Alexandra, et al.
Publicado: (2026)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
por: Thomas, Owen, et al.
Publicado: (2024)

Clustering-Based Outcome Models for Clinical Studies: A Scoping Review
por: Vilsmeier, Johannes, et al.
Publicado: (2026)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
por: Gu, Xuemin, et al.
Publicado: (2026)

Diagnostics for Regression Models with Semicontinuous Outcomes
por: Yang, Lu
Publicado: (2024)

Profile Monitoring via Eigenvector Perturbation
por: Iguchi, Takayuki, et al.
Publicado: (2022)

Statistical Design of Pragmatic Trials Using Electronic Health Record Data when Outcome Assessments are Uncontrolled and Irregular
por: Bobb, Jennifer F., et al.
Publicado: (2026)

ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
por: Wang, Shuqi, et al.
Publicado: (2024)

Monitoring 3D Lattice Structures in Additive Manufacturing Using Topological Data Analysis
por: An, Yulin, et al.
Publicado: (2025)

Generalizing Trimming Bounds for Endogenously Missing Outcome Data Using Random Forests
por: Samii, Cyrus, et al.
Publicado: (2023)

Joint Modeling of Longitudinal EHR Data with Shared Random Effects for Informative Visiting and Observation Processes
por: Yang, Cheng-Han, et al.
Publicado: (2026)

Double Probability Integral Transform Residuals for Regression Models with Discrete Outcomes
por: Yang, Lu
Publicado: (2023)

Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies
por: Yuan, Shijie, et al.
Publicado: (2025)

Estimating Causal Effects for Binary Outcomes Using Per-Decision Inverse Probability Weighting
por: Bao, Yihan, et al.
Publicado: (2023)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
por: Hall, Andrew, et al.
Publicado: (2025)

HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
por: Shi, Junming, et al.
Publicado: (2024)

Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
por: Zhang, Jiangshan, et al.
Publicado: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
por: Lee, Kyong Ju, et al.
Publicado: (2025)

A Tutorial on Conducting Mediation Analysis with Exposure Mixtures
por: Wang, Yiran, et al.
Publicado: (2025)

Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
por: Yamada, Kana, et al.
Publicado: (2026)

Nonparametric Monitoring of Spatial Dependence
por: Adämmer, Philipp, et al.
Publicado: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
por: Yang, Peng, et al.
Publicado: (2026)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
por: Coent, Quentin Le, et al.
Publicado: (2025)

Spherically Embedded Time Series with Unknown Trend and Periodic Components
por: Xu, Jiazhen, et al.
Publicado: (2026)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
por: Zhang, Hong, et al.
Publicado: (2023)

Differential item functioning via robust scaling
por: Halpin, Peter F.
Publicado: (2022)

On Weighted Trigonometric Regression for Suboptimal Designs in Circadian Biology Studies
por: Gorczyca, Michael, et al.
Publicado: (2024)

Forecasting high-dimensional functional time series with dual-factor structures
por: Tang, Chen, et al.
Publicado: (2021)

Personalized Biopsy Schedules Using an Interval-censored Cause-specific Joint Model
por: Yang, Zhenwei, et al.
Publicado: (2022)

Semiparametric Inference for Causal Effects on Functional Outcomes
por: Nie, Junzhu, et al.
Publicado: (2026)

Anchoring Convenience Survey Samples to a Baseline Census for Vaccine Coverage Monitoring in Global Health
por: Dyrkton, Nathaniel, et al.
Publicado: (2025)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
por: Yuan, Shijie, et al.
Publicado: (2025)